J.P.T. Moreira

Characterization of <i>ERG</i> , <i>AR</i> and <i>PTEN</i> Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer

Gerhardt Attard, Joost F. Swennenhuis, David Olmos et al. · Cancer Research · 2009 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.

Howard I. Scher, Glenn Heller, Ana M. Molina et al. · Journal of Clinical Oncology · 2011 · 113 citations

Medicine, Oncology, Pharmacology +17

Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity

Gerhardt Attard, Charles Jameson, J.P.T. Moreira et al. · Journal of Clinical Pathology · 2008 · 24 citations

Medicine, Oncology, Urology +17